These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16544822)

  • 1. "Testing superiority and non-inferiority hypotheses in active controlled clinical trials".
    Röhmel J; Hauschke D
    Biom J; 2006 Feb; 48(1):174-5; author reply 176. PubMed ID: 16544822
    [No Abstract]   [Full Text] [Related]  

  • 2. Testing superiority and non-inferiority hypotheses in active controlled clinical trials.
    Tsong Y; Zhang JJ
    Biom J; 2005 Feb; 47(1):62-74; discussion 99-107. PubMed ID: 16395997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biostatistical assessment of mutagenicity studies by including the positive control.
    Hauschke D; Slacik-Erben R; Hensen S; Kaufmann R
    Biom J; 2005 Feb; 47(1):82-7; discussion 99-107. PubMed ID: 16395999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic equivalence--clinical issues and statistical methodology in noninferiority trials.
    Munk A; Trampisch HJ
    Biom J; 2005 Feb; 47(1):7-9; discussion 99-107. PubMed ID: 16395992
    [No Abstract]   [Full Text] [Related]  

  • 5. Problems with existing procedures to calculate exact unconditional P-values for non-inferiority/superiority and confidence intervals for two binomials and how to resolve them.
    Röhmel J
    Biom J; 2005 Feb; 47(1):37-47; discussion 99-107. PubMed ID: 16395995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trials.
    Hung HM; Wang SJ; O'Neill R
    Biom J; 2005 Feb; 47(1):28-36; discussion 99-107. PubMed ID: 16395994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical methods for the analysis of two-arm non-inferiority trials with binary outcomes.
    Wellek S
    Biom J; 2005 Feb; 47(1):48-61; discussion 99-107. PubMed ID: 16395996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior safety in noninferiority trials.
    Bristol DR
    Biom J; 2005 Feb; 47(1):75-81; discussion 99-107. PubMed ID: 16395998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of delta: requirements and reality--results of a systematic review.
    Lange S; Freitag G
    Biom J; 2005 Feb; 47(1):12-27; discussion 99-107. PubMed ID: 16395993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
    Hirotsu C
    Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Issues of simultaneous tests for noninferiority and superiority.
    Ng TH
    J Biopharm Stat; 2003 Nov; 13(4):629-39; discussion 641-62. PubMed ID: 14584713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trial.
    Sankoh AJ
    Stat Med; 2008 Aug; 27(19):3732-42. PubMed ID: 18407575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials.
    Lai TL; Shih MC; Zhu G
    Stat Med; 2006 Apr; 25(7):1149-67. PubMed ID: 16189814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.
    Wang SJ; Hung HM; Tsong Y; Cui L
    Stat Med; 2001 Jul; 20(13):1903-12. PubMed ID: 11427948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo.
    Pigeot I; Schäfer J; Röhmel J; Hauschke D
    Stat Med; 2003 Mar; 22(6):883-99. PubMed ID: 12627407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-parametric assessment of non-inferiority with censored data.
    Freitag G; Lange S; Munk A
    Stat Med; 2006 Apr; 25(7):1201-17. PubMed ID: 16345041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y; Zhang J
    J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for assessing noninferiority with censored data.
    Freitag G
    Biom J; 2005 Feb; 47(1):88-98; discussion 99-107. PubMed ID: 16396000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approximate sample sizes for testing hypotheses about the ratio and difference of two means.
    Kieser M; Hauschke D
    J Biopharm Stat; 1999 Nov; 9(4):641-50. PubMed ID: 10576408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for and methods of superiority, noninferiority, or equivalence designs in orthopaedic, controlled trials.
    Vavken P
    Clin Orthop Relat Res; 2011 Sep; 469(9):2645-53. PubMed ID: 21246313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.